Investment Type: Venture Capital
Investment Stage: Series B
Portfolio 1
Date | Name | Website | Total Raised | Location |
24.10.2022 | Resolve Bi... | resolvebiosciences.com | $71M | Germany, B... |
Mentions in press and media 2
Date | Title | Description |
04.02.2009 | Arcxis pulls in funds to diagnose gene-linked diseases | Arcxis Biotechnologies, a Pleasanton, Calif. biotech tool maker focused on DNA analysis — especially for diagnostic purposes — just closed an undisclosed sum (higher than $8 million) toward an anticipated $15 million second round of funding... |
09.01.2009 | Gene Security Network strings together $6M for in-vitro tech | Gene Security Network, provider of a test used to screen chromosomes in in-vitro fertilization processes, has brought in $6 million in second-round funding to grow its sales and marketing operations. The investment, paired with grants recei... |